MiR-30b-5p inhibits proliferation and promotes apoptosis of medulloblastoma cells via targeting MYB proto-oncogene like 2 (MYBL2).

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
Chengyan XuZhipeng Shen

Abstract

Medulloblastoma (MB) is the most common malignant brain tumors among children. MiR-30b-5p is a potential tumor suppressor in a variety of human cancers. However, its expression and function in MB remain poorly understood. This study aimed to investigate the expression, role and regulatory mechanism of miR-30b-5p in MB. The expression of miR-30b-5p in MB tissues and cell lines was detected by real-time PCR. The effects of miR-30b-5p on cell proliferation and apoptosis were monitored by CCK-8 (Cell Counting Kit-8) assay, colony formation assay and flow cytometry, respectively. Bioinformatics database TargetScan predicted the target genes of miR-30b-5p. The interaction between miR-30b-5p and MYB proto-oncogene Like 2 (MYBL2) was determined by luciferase reporter gene assay. We demonstrated that the expression of miR-30b-5p was significantly downregulated in MB. Upregulated miR-30b-5p could inhibit the proliferation and induce apoptosis of MB.Moreover, overexpressed miR-30b-5p could increase the expression of BAX but decrease that of Bcl-2. Downregulated miR-30b-5p exerted the opposite effect. MYBL2 was proved to be the target gene of miR-30b-5p and was negatively regulated by miR-30b-5p. These results indicate that miR-30b-5p inhi...Continue Reading

References

Oct 4, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Arturo Sala
Dec 29, 2010·Proceedings of the National Academy of Sciences of the United States of America·Ivan MartinezDaniel DiMaio
Jul 9, 2011·Molecular Neurobiology·Richard HummelJoerg Haier
Mar 27, 2013·Pediatric Hematology and Oncology·Daniel Onofre VidalRui Manuel Reis
May 9, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tarek ShalabyMichael A Grotzer
May 27, 2014·Advanced Drug Delivery Reviews·Yunching ChenLeaf Huang
Oct 29, 2014·International Journal of Cancer. Journal International Du Cancer·Theresa ThorJohannes H Schulte
Apr 14, 2015·BioMed Research International·Sebastian López-OchoaFrancisco Arenas-Huertero
Jun 13, 2015·Stem Cells International·Neha GargSheila K Singh
Aug 27, 2015·World Journal of Gastroenterology : WJG·Shu-Bo TianChao Yan
Jul 14, 2016·Journal of Neuro-oncology·Yongxiao LiQing Chang
Feb 13, 2017·Biochemical and Biophysical Research Communications·Qing LiDongfeng Chen
Aug 2, 2017·Biochemical and Biophysical Research Communications·Satishkumar Vishram SinghNeelam Vishwanath Shirsat
Oct 12, 2018·Cell Death & Disease·Kui ZhangHongjuan Cui
Dec 26, 2018·Cancers·Ryte RynkevicieneKestutis Suziedelis
Feb 16, 2019·Nature Reviews. Disease Primers·Paul A NorthcottStefan M Pfister
Mar 17, 2019·Journal of Hematology & Oncology·Otília MenyhártBalázs Győrffy
May 10, 2019·Journal of Cellular Physiology·Golamreza JadideslamAlireza Kabbazi
May 19, 2019·Clinical Chemistry·Sugarniya SubramaniamJyotsna Batra
May 19, 2019·Free Radical Biology & Medicine·Solmaz ShirjangBehzad Baradaran
May 31, 2020·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Yu-Hang ZhangXiangYin Kong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis